Published in Am J Psychiatry on September 01, 2000
Psychiatric comorbidities and schizophrenia. Schizophr Bull (2008) 2.69
Research Domain Criteria: cognitive systems, neural circuits, and dimensions of behavior. Dialogues Clin Neurosci (2012) 2.45
Psychiatric symptoms and quality of life in schizophrenia: a meta-analysis. Schizophr Bull (2007) 1.76
Atypical antipsychotics for people with both schizophrenia and depression. Cochrane Database Syst Rev (2008) 1.47
Are antipsychotics or antidepressants needed for psychotic depression? A systematic review and meta-analysis of trials comparing antidepressant or antipsychotic monotherapy with combination treatment. J Clin Psychiatry (2012) 1.14
Schizophrenia in the internalizing-externalizing framework: a third dimension? Schizophr Bull (2010) 1.14
Physical comorbidity and its relevance on mortality in schizophrenia: a naturalistic 12-year follow-up in general hospital admissions. Eur Arch Psychiatry Clin Neurosci (2013) 1.07
Treating bipolar disorder. Evidence-based guidelines for family medicine. Can Fam Physician (2004) 1.04
The complement system in schizophrenia. Drug News Perspect (2008) 1.02
Neuroleptic dysphoria: towards a new synthesis. Psychopharmacology (Berl) (2003) 0.98
Measurement of functional capacity: a new approach to understanding functional differences and real-world behavioral adaptation in those with mental illness. Annu Rev Clin Psychol (2010) 0.94
Depression in schizophrenia: methodological artifact or distinct feature of the illness? J Neuropsychiatry Clin Neurosci (2008) 0.93
An epidemiologic and clinical overview of medical and psychopathological comorbidities in major psychoses. Eur Arch Psychiatry Clin Neurosci (2011) 0.91
Exercise Improves Clinical Symptoms, Quality of Life, Global Functioning, and Depression in Schizophrenia: A Systematic Review and Meta-analysis. Schizophr Bull (2015) 0.90
The relationships between depression and remission in first-episode psychosis. World Psychiatry (2006) 0.90
Reliability and validity of the Calgary Depression Scale for Schizophrenia (CDSS) in youth at clinical high risk for psychosis. Schizophr Res (2014) 0.89
Substantial genetic overlap between schizotypy and neuroticism: a twin study. Behav Genet (2012) 0.89
Unmet needs in the management of schizophrenia. Neuropsychiatr Dis Treat (2014) 0.88
Deficits in emotional awareness in schizophrenia and their relationship with other measures of functioning. J Nerv Ment Dis (2009) 0.83
Pharmacotherapy of schizophrenic patients: preponderance of off-label drug use. PLoS One (2008) 0.83
Impact of depressive symptoms on subjective well-being: the importance of patient-reported outcomes in schizophrenia. Patient Prefer Adherence (2011) 0.82
Forms of antipsychotic therapy: improved individual outcomes under personalised treatment of schizophrenia focused on depression. EPMA J (2011) 0.80
Evaluation of Myo-Inositol as a Potential Biomarker for Depression in Schizophrenia. Neuropsychopharmacology (2015) 0.80
The relationship between depressive syndrome and suicidal risk in patients with acute schizophrenia. Croat Med J (2013) 0.80
Schizophrenia and the eye. Schizophr Res Cogn (2015) 0.79
Anti-depressive effectiveness of olanzapine, quetiapine, risperidone and ziprasidone: a pragmatic, randomized trial. BMC Psychiatry (2011) 0.79
Antipsychotic Prescribing Patterns in First-episode Schizophrenia: A Five-year Comparison. Clin Psychopharmacol Neurosci (2015) 0.78
Depression and Schizophrenia: Cause, Consequence, or Trans-diagnostic Issue? Schizophr Bull (2017) 0.77
Elderly patients with schizophrenia and depression: diagnosis and treatment. Clin Schizophr Relat Psychoses (2011) 0.77
Study of Relationship Between Depression and Quality of Life in Patients With Chronic Schizophrenia. Glob J Health Sci (2015) 0.77
The drug-induced helplessness test: an animal assay for assessing behavioral despair in response to neuroleptic treatment. Psychopharmacology (Berl) (2006) 0.77
Schizophrenia: a systemic disorder. Clin Schizophr Relat Psychoses (2014) 0.77
A Pilot Study for Discovering Candidate Genes of Chromosome 18q21 in Methamphetamine Abusers: Case-control Association Study. Clin Psychopharmacol Neurosci (2014) 0.76
Lurasidone for the treatment of depressive symptoms in schizophrenia: analysis of 4 pooled, 6-week, placebo-controlled studies. CNS Spectr (2014) 0.76
Atypical antipsychotics in the treatment of depressive and psychotic symptoms in patients with chronic schizophrenia: a naturalistic study. Schizophr Res Treatment (2013) 0.76
Guidelines for the Pharmacotherapy of Schizophrenia in Adults. Can J Psychiatry (2017) 0.76
The "Insight Paradox" in Schizophrenia: Magnitude, Moderators and Mediators of the Association Between Insight and Depression. Schizophr Bull (2016) 0.75
Personality trait correlates of color preference in schizophrenia. Transl Neurosci (2015) 0.75
Confirmatory Factor Analysis and Differential Relationships of the Two Subdomains of Negative Symptoms in Chronically Ill Psychotic Patients. PLoS One (2016) 0.75
Clozapine and co-prescribed psychotropics: a short report. Clin Pract Epidemiol Ment Health (2008) 0.75
Treating depression in schizophrenia. Am J Psychiatry (2001) 0.75
Combination therapy or monotherapy for the depressed type of schizoaffective disorder. Neuropsychiatr Dis Treat (2009) 0.75
Association Between Cardiovascular Risk and Depressive Symptoms Among People With Serious Mental Illness. J Nerv Ment Dis (2017) 0.75
Comorbid Moderate-Severe Depressive Symptoms and their Association with Quality of Life in Chinese Patients with Schizophrenia Treated in Primary Care. Community Ment Health J (2016) 0.75